Results 201 to 210 of about 8,764,171 (325)
The crystal structure of the RNA/DNA hybrid r(GAAGAGAAGC){middle dot}d(GCTTCTCTTC) shows significant differences to that found in solution [PDF]
Graeme L. Conn +2 more
openalex +1 more source
International operations and corporate R&D investment: Evidence from China. [PDF]
Fu Y, Li J, Wu Y.
europepmc +1 more source
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann +61 more
wiley +1 more source
A Framework for Considering the Role of the Public Sector in R&D of Health Technology. [PDF]
Rejon-Parrilla JC +3 more
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Strategic resilience: Exploring diversification's impact on R&D investment during economic crises. [PDF]
Nguyen TBC, Nguyen QN.
europepmc +1 more source
Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic +5 more
wiley +1 more source

